Imatinib plasma levels: correlation with clinical benefit in GIST patients

Br J Cancer. 2010 Mar 30;102(7):1198-9. doi: 10.1038/sj.bjc.6605584. Epub 2010 Feb 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Albumins / metabolism
  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Dose-Response Relationship, Drug
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / genetics
  • Gastrointestinal Stromal Tumors / metabolism
  • Genotype
  • Glycoproteins / metabolism
  • Humans
  • Imatinib Mesylate
  • Piperazines / blood*
  • Piperazines / pharmacokinetics
  • Piperazines / therapeutic use
  • Pyrimidines / blood*
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / therapeutic use
  • Treatment Outcome

Substances

  • Albumins
  • Antineoplastic Agents
  • Benzamides
  • Glycoproteins
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate